Records containing: Lupus Erythematosus, Systemic
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2022-07-08A Single Arm, 24 Weeks, Pilot Study of Belimumab In Treatment of Early Systemic Lupus Erythematosus
-
CLINICAL_TRIALS study record update · 2022-06-01Employment and Arthritis: Making it Work: A Randomized Controlled Trial Evaluating an On-line Program to Help People With Inflammatory Arthritis Remain Employed
-
CLINICAL_TRIALS study record update · 2022-05-20Searching for Diagnostic/Prognostic Biomarkers in Systemic Lupus Erythematosus (SLE) With Renal Involvement by Proteomic Techniques. A Multicentre Study
-
CLINICAL_TRIALS study record update · 2022-05-19Effectiveness of Custom-made Foot Orthoses in Patients With Systemic Lupus Erythematous
-
CLINICAL_TRIALS study record update · 2022-04-14Effect of Cholecalciferol Supplementation on Disease Activity and Quality of Life of Systemic Lupus Erythematosus Patients
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2022-03-22A Widespread Self-management Education Program to Reduce Health Disparities in African American Women With Systemic Lupus Erythematosus
-
CLINICAL_TRIALS study record update · 2022-03-09A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Ustekinumab in Subjects With Active Systemic Lupus Erythematosus
-
CLINICAL_TRIALS study record update · 2021-11-15A Phase Ib, Multicentre, Randomised, Double-blind, Placebo Controlled, 8 Week Crossover Study to Assess the Safety, Tolerability and Pharmacokinetics of Orally Administered BI 705564 in Patients With Systemic Lupus Erythematosus.
-
CLINICAL_TRIALS study record update · 2021-09-16Lessening the Impact of Fatigue in Inflammatory Rheumatic Diseases: A Randomised Clinical Trial
-
CLINICAL_TRIALS study record update · 2021-08-19A Phase Ib Study of Milatuzumab Administered Subcutaneously in Patients With Active Systemic Lupus Erythematosus (SLE)
-
CLINICAL_TRIALS study record update · 2021-05-24Comparison of Complement Factors and Genetic Polymorphisms of AMD Between Patients With Systemic Lupus Erythematosus (SLE) With and Without Retinal "Pseudo-drusen-like" Deposits: Case-control Study (PLAMD)
-
CLINICAL_TRIALS study record update · 2021-03-04A Phase 1, Randomized, Placebo-Controlled, Multiple- Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Subcutaneous LY3361237 in Patients With Systemic Lupus Erythematosus
-
CLINICAL_TRIALS study record update · 2021-02-24Role of the Neonatal Fc Receptor for IgG in the Pathophysiology of Lupus
-
CLINICAL_TRIALS study record update · 2021-02-18A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF CC-220 IN SUBJECTS WITH ACTIVE SYSTEMIC LUPUS ERYTHEMATOSUS
-
CLINICAL_TRIALS study record update · 2020-12-19A Phase II, Open-Label Extension Study of Patients Previously Enrolled in Study GA30044 to Evaluate the Long-Term Safety and Efficacy of GDC-0853 in Patients With Moderate to Severe Active Systemic Lupus Erythematosus
-
CLINICAL_TRIALS study record update · 2020-09-16Establishing Clinical Utility of a New Diagnostic Test for Rheumatology Patients: A CPV® Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2020-09-09Using the Cholinergic Anit-Inflammatory Pathway to Treat Systemic Lupus Musculoskeletal Pain
-
CLINICAL_TRIALS study record update · 2020-08-20A Multicenter, Randomized, Double Blind, Placebo Controlled Study to Assess the Efficacy and Safety of Acthar Gel in Subjects With Persistently Active Systemic Lupus Erythematosus Despite Moderate Dose Corticosteroids
-
CLINICAL_TRIALS study record update · 2020-08-19Open-label, Monocentric, Phase II, Investigator-initiated Clinical Trial on Unbiased Characterization of Immunological Parameters in Interleukin-2-treated Systemic Lupus Erythematosus
-
CLINICAL_TRIALS study record update · 2020-07-08A Randomized, Double-Blind, Active Comparator-Controlled, Crossover Study to Assess the Capacity of RAYOS® Compared to Immediate-Release Prednisone to Improve Fatigue and Control Morning Symptoms in Subjects With Systemic Lupus Erythematosus
-
CLINICAL_TRIALS study record update · 2020-06-29Mobile Study to Measure and Predict Lupus Disease Activity Using Digital Signals
-
CLINICAL_TRIALS study record update · 2020-05-20Internet-Based Pain Coping Skills Training (PainCOACH) for Patients With Lupus
-
CLINICAL_TRIALS study record update · 2020-04-24Understanding the Role Played by Serum and Membrane Lipids in Immune Cell Function in Patients With Systemic Lupus Erythematosus (SLE) and Healthy Donors
-
CLINICAL_TRIALS study record update · 2020-04-01Bone Mineral Density of Children and Adolescents With Systemic Lupus Erythematosus
-
CLINICAL_TRIALS study record update · 2020-01-13Interactive Digital Technology (Project EVO) to Assess and Improve Cognitive Dysfunction in Patients With Systemic Lupus Erythematosus (SLE)